President Donald Trump’s budget outline for fiscal 2018 could throw a monkey wrench in the FDA user-fee reauthorization process currently underway, which in turn could deprive the cosmetics industry of a promising opportunity to fast-track regulatory reform.
Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.
More from Regulation
FDA publishes the first proposed rule under the Modernization of Cosmetics Regulation Act – a testing method for detecting asbestos in talc-containing cosmetics.
Many small US and independent beauty brands are still unfamiliar with the Modernization of Cosmetics Regulation Act, as are owners of beauty brands based outside the US; the lack of education about the regulation is making many stakeholders at risk for non-compliance.
The Biden Administration’s final unified agenda sets target dates for three notices of proposed rulemakings under MoCRA, setting a proposal for cosmetic GMPs for October 2025.
California’s Department of Toxic Substances Control issues a proposed rulemaking for methyl methacrylate alternatives in nail products, years after identifying the ingredient for prioritization.
More from Policy & Regulation
The Biden Administration’s final unified agenda sets target dates for three notices of proposed rulemakings under MoCRA, setting a proposal for cosmetic GMPs for October 2025.
FDA publishes an updated registration guidance in the Federal Register 12 December to answer outstanding questions by stakeholders, including whether a single FEI number can be used for multiple related facilities.
Guest authors Marcha Isabelle Chaudry, an attorney and founder of the Equity and Wellness Collaborative, and Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP, write about the risks companies face in making claims in the realm of ‘green’ beauty, where an absence of a universal standard or definition for ‘green’ is creating confusion and in some cases, legal headaches.